Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




TNF Antagonists Not Linked to Major Malignant Lymphoma Risk in RA Patients
Link ID 16213
Title TNF Antagonists Not Linked to Major Malignant Lymphoma Risk in RA Patients
Url http://www.medscape.com/viewarticle/703758?src=rss
Description Anti-tumor necrosis factor (TNF) therapy does not markedly increase the risk of malignant lymphoma in patients with rheumatoid arthritis, according to the results of a Swedish study. This study is one of the largest to-date to assess effects of anti-TNF therapy in rheumatoid arthritis patients. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Jun 4, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. A Rash of New Developments in Psoriatic Arthritis
  A summary by Philip Mease, MD, of new developments for the management of psoriatic arthritis as illustrated by data presented at EULAR 2008.
Medscape Rheumatology
Category:   Articles > Rheumatology


2. New Insights Into Osteoarthritis: Early Developmental Features of an Ageing-related Disease
  This review addresses how recently identified consistent osteoarthritis susceptibility genes influence both the onset of osteoarthritis, and its progression towards clinical outcomes.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


3. Dual-Energy CT May Help in Evaluating Gout
  Dual-energy computed tomography (CT) is a sensitive and specific way to detect early changes in gout. Medscape Medical News
Category:   Articles > Rheumatology


4. Polymorphisms Within the Adenosine Receptor 2a Gene Are Associated With Adverse Events in RA Patient
  There is increasing interest in the potential of pharmacogenetics to guide therapeutic decision making. Understanding methotrexate pharmacogenetics may determine as to which patients are most likely to respond to treatment and/or which patients may be more susceptible to toxicity.
Rheumatology
Category:   Articles > Rheumatology


5. Bosentan Not an Option for Interstitial Lung Disease Due to Systemic Sclerosis
  The endothelin receptor antagonist bosentan is ineffective for interstitial lung disease due to systemic sclerosis, according to new data. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS